Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsprofessional-practice-and-evidence

Paeds SAQs · professional-practice-and-evidence

Clinical epidemiology and measures of effect — formative SAQs

Formative SAQs on the computation and interpretation of measures of effect in paediatric research.

20 marks30 min4 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH TheoryABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH TheoryABP General Pediatrics
Prompt
Clinical epidemiology and measures of effect

SAQ 1 (10 marks)

You are asked to interpret the results of a randomised controlled trial of a preventive therapy in children. The trial reports the outcome in 200 of 1,000 controls and 100 of 1,000 treated children, and the abstract quotes a 50 percent relative risk reduction. [1]

  1. From the data provided, compute the relative risk, the relative risk reduction, the absolute risk reduction, and the number needed to treat, showing your working. (4) [3] [4]
  2. Explain why quoting only the 50 percent relative risk reduction is misleading, and describe how you would present the benefit accurately to a family. (3) [3] [8]
  3. Explain how the number needed to treat would change if the child's baseline risk were 2 percent rather than 20 percent, and what this implies for applying the result. (3) [3] [4]

Model answer

The risk in controls is 200 divided by 1,000, which is 0.20 or 20 percent, and the risk in the treated group is 100 divided by 1,000, which is 0.10 or 10 percent. The relative risk is the risk in the treated group divided by the risk in controls, 0.10 divided by 0.20, which is 0.5. The relative risk reduction is one minus the relative risk, which is 0.5 or 50 percent. The absolute risk reduction is the risk in controls minus the risk in the treated group, 0.20 minus 0.10, which is 0.10 or 10 percent. The number needed to treat is the reciprocal of the absolute risk reduction, 1 divided by 0.10, which is 10, rounded up to the next whole person. [3] [4]

The 50 percent relative risk reduction is misleading because it hides the baseline risk and inflates the perceived benefit. I would present the absolute risk reduction and the number needed to treat alongside the relative figure, explaining that out of ten children treated, one event is prevented, and I would read the confidence interval so the family understands the range compatible with the data. The absolute figure is benefit family can feel, so it should always accompany the relative one. [3] [8]

If the child's baseline risk were 2 percent rather than 20 percent, the same 50 percent relative risk reduction would produce an absolute risk reduction of 1 percent and a number needed to treat of 100, a tenth of the absolute benefit. This shows that the number needed to treat is only as honest as the baseline risk behind it, so it must be recomputed for the child's own baseline risk rather than borrowed from the trial average. [3] [4]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References11ShowHide
  1. [1]Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS Evidence based medicine: what it is and what it isn't BMJ, 1996.PMID 8555924
  2. [2]Guyatt GH, Sackett DL, Cook DJ Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group JAMA, 1994.PMID 8258890
  3. [3]Laupacis A, Sackett DL, Roberts RS An assessment of clinically useful measures of the consequences of treatment N Engl J Med, 1988.PMID 3374545
  4. [4]Cook RJ, Sackett DL The number needed to treat: a clinically useful measure of treatment effect BMJ, 1995.PMID 7873954
  5. [5]Davies HT, Crombie IK, Tavakoli M When can odds ratios mislead? BMJ, 1998.PMID 9550961
  6. [6]Zhang J, Yu KF What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA, 1998.PMID 9832001
  7. [7]Spruance SL, Reid JE, Grace M, Samore M Hazard ratio in clinical trials Antimicrob Agents Chemother, 2004.PMID 15273082
  8. [8]Greenhalgh T How to read a paper. Statistics for the non-statistician. II: Significant relations and their pitfalls BMJ, 1997.PMID 9277611
  9. [9]Altman DG, Bland JM Absence of evidence is not evidence of absence BMJ, 1995.PMID 7647644
  10. [10]Grimes DA, Schulz KF Bias and causal associations in observational research Lancet, 2002.PMID 11812579
  11. [11]Murad MH, Montori VM, Ioannidis JP, et al. How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature JAMA, 2014.PMID 25005654
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousBreaking bad news and serious-illness communication — formative SAQsprofessional-practice-and-evidenceNextClinician wellbeing, fatigue and sustainable practice — formative SAQsprofessional-practice-and-evidence